OTCMKTS:SHTDY Sinopharm Group (SHTDY) Stock Price, News & Analysis → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free SHTDY Stock Alerts $13.88 +0.12 (+0.87%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$13.80▼$13.8850-Day Range$12.21▼$14.4452-Week Range$11.36▼$18.01Volume2,555 shsAverage Volume13,163 shsMarket CapitalizationN/AP/E Ratio2.78Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartDividendFinancialsHeadlinesShort InterestStock AnalysisChartDividendFinancialsHeadlinesShort Interest Get Sinopharm Group alerts: Email Address Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> About Sinopharm Group Stock (OTCMKTS:SHTDY)Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.Read More SHTDY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SHTDY Stock News HeadlinesApril 15, 2024 | americanbankingnews.comShort Interest in Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY) Expands By 33.5%April 13, 2024 | morningstar.comSinopharm Group Co LtdApril 25, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.April 8, 2024 | msn.comStudy: Pfizer vaccine showed strongest immune response in MoroccoMarch 27, 2024 | markets.businessinsider.comBuy Rating for Sinopharm Group Co. Amidst Market Consolidation and Efficiency GainsMarch 15, 2024 | tmcnet.comXinhua Silk Road: Electric tricycles made in E. China's Rizhao popular abroadFebruary 25, 2024 | msn.comSinopharm Group Co. - Depositary Receipt () (SHTDY) Price Target Increased by 11.16% to 15.28February 22, 2024 | msn.comHong Kong Stocks: Sinopharm to Buyout China-TCM for HK$23.2BApril 25, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.February 21, 2024 | uk.finance.yahoo.comPharma Wholesale and Distribution market is projected to grow at a CAGR of 8.7% by 2034: VisiongainFebruary 19, 2024 | thestreet.comSinopharm Group Co Ltd ADRNovember 7, 2023 | morningstar.comSinopharm Group Co Ltd ADR SHTDYSeptember 5, 2023 | finance.yahoo.comHong Kong stocks slide amid China property default risk while Sinopharm slides on index debut, L'Occitane crashesMay 18, 2023 | msn.comWHO recommends updating COVID shots to add XBB.1 variantsMarch 30, 2023 | marketwatch.comChlorpheniramine Maleate Market Outlook and Forecast till 2031March 29, 2023 | morningstar.comSinopharm’s Earnings Slightly Better Than ExpectedMarch 29, 2023 | marketwatch.com2023-2029 Gold(III) Bromide (AuBr3) Market Size and Industrial Overview with Region Footprint | Latest Report by Absolute ReportsMarch 28, 2023 | marketwatch.com7-Aminocephalosporanic Acid (7-ACA) Market Outlook By 2031March 27, 2023 | marketwatch.comSpecialty Pharmacy Services Market Outlook By 2031March 24, 2023 | marketwatch.comGosling Plague Vaccine Market Top Players By 2031March 23, 2023 | marketwatch.comNew Report Predicts Significant Growth in Polysorbate 40 Market from 2023 to 2030March 21, 2023 | marketwatch.comGlobal Cobamamide Drugs Market: Future Extrapolations and Emerging Updates for 2023-2027March 21, 2023 | marketwatch.comChain Drugstores Market Top Players and Forecast till 2029March 13, 2023 | marketwatch.comAmmonium Phosphomolybdate Market Size, Share and Forecast 2028 with Top Countries DataMarch 13, 2023 | marketwatch.comChain Drugstores Market Size 2023 Will Grow Rapidly Another Level In The Forthcoming Year 2029March 10, 2023 | marketwatch.comTacrolimus Consumption Market Size, Growth Rate, Key Players Share, Trends Analysis with Forecast 2023-2029March 8, 2023 | marketwatch.comPolysorbate 40 Market Size 2023 Will Grow Rapidly Another Level In The Forthcoming Year 2030See More Headlines Receive SHTDY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Distribution Sub-IndustryN/A Current SymbolOTCMKTS:SHTDY CUSIPN/A CIK1556605 Webwww.sinopharmgroup.com.cn Phone86-21-2305-2666FaxN/AEmployees115,959Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio2.78 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Qingming Yu (Age 60)Executive Chairman of the Board Comp: $896.92kMr. Yong Liu (Age 55)President & Executive Director Comp: $867.34kMs. Xiaojuan Li (Age 48)Chief Financial Officer Mr. Yijian Wu (Age 54)Secretary to the Board, Company Secretary & Authorised Representative Key CompetitorsAlfresaOTC:ARHCFArjo AB (publ)OTCMKTS:ARRJFEBOS GroupOTCMKTS:EBOSFGalenicaOTCMKTS:GALNFMcKesson EuropeOTCMKTS:CAKFYView All Competitors SHTDY Stock Analysis - Frequently Asked Questions How have SHTDY shares performed in 2024? Sinopharm Group's stock was trading at $13.05 on January 1st, 2024. Since then, SHTDY shares have increased by 6.4% and is now trading at $13.88. View the best growth stocks for 2024 here. Are investors shorting Sinopharm Group? Sinopharm Group saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 23,200 shares, a decrease of 22.4% from the March 31st total of 29,900 shares. Based on an average daily volume of 20,000 shares, the short-interest ratio is currently 1.2 days. View Sinopharm Group's Short Interest. How often does Sinopharm Group pay dividends? What is the dividend yield for Sinopharm Group? Sinopharm Group declared a dividend on Thursday, June 15th. Investors of record on Friday, June 16th will be given a dividend of $0.4862 per share on Tuesday, August 29th. This represents a yield of 2.85%. The ex-dividend date is Thursday, June 15th. Read our dividend analysis for SHTDY. How do I buy shares of Sinopharm Group? Shares of SHTDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SHTDY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
